PuriCore (LSE: PURI), the life sciences company focused on the development and
commercialisation of its novel, safe antimicrobial technology, today announces
that its Sterilox Endoscopy division has signed an exclusive distribution
agreement with Minntech Corporation ("Minntech"), one of the world's leading
manufacturers of automated endoscope reprocessors ("AER"), and a subsidiary of
Cantel Medical Corp (NYSE: CMN).